Börse Express - Professor Lars Iversen joins MC2 Therapeutics as new Chief Medical Officer

Copenhagen (ots/PRNewswire) - MC2 Therapeutics A/S, a commercial stage pharmaceutical company, has named Lars Iversen, MD, DMSc an esteemed chair professor in dermatology at Aarhus University Hospital and at Aarhus University, its new full-time Chief Medical Officer (CMO) as of October 1st, 2022.Professor Lars Iversen will be a key member of the Ex...

Related Keywords

United States ,Denmark ,Copenhagen ,Køavn ,Danish ,Lars Iversen ,Johan Selmer ,Jesperj Lange ,National Center ,European Society Of Dermatological Research ,Danish Dermatological Society ,Nordic Dermatological Association ,University Of Aarhus ,Therapeutics Group ,International Psoriasis Council ,European Skin Research Fund ,Aarhus University Hospital ,Autoimmune Diseases At Aarhus University Hospital ,Aarhus University ,Chief Medical Officer ,Executive Team ,Autoimmune Diseases ,Professor Lars ,Executive Medical Advisor ,Professor Lars Iversen ,Scientific Advisory ,European Society ,Dermatological Research ,Topical Treatment Working Group ,Nordic Dermatological ,Wirtschaft ,